In HeLa, H2009, and MDA-MB231 cancer cells, MLKL enhances cancer cell death by increasing endocytosis and endosomal trafficking of TRAIL-DR5 apoptotic signals compared to control cells (Park et al., 2020). Here, MLKL is linked to cancer.